Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials.
about
Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancerUK guidelines for the management of bone sarcomasMusculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniquesEMT, CTCs and CSCs in tumor relapse and drug-resistancePulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data.A case report of apatinib in treating osteosarcoma with pulmonary metastases.Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness?Epidemiology and therapies for metastatic sarcomaRecurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review.Doxorubicin activates the Notch signaling pathway in osteosarcoma.Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic GroupsGenistein sensitizes sarcoma cells in vitro and in vivo by enhancing apoptosis and by inhibiting DSB repair pathwaysThe effect of electroacupuncture on osteosarcoma tumor growth and metastasis: analysis of different treatment regimens.Osteosarcoma follow-up: chest X-ray or computed tomography?Adoptive immunotherapy against sarcomas.Advances in emerging drugs for osteosarcoma.An update on chemotherapy for osteosarcoma.Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients.A 20-year retrospective analysis of CT-based pre-operative identification of pulmonary metastases in patients with osteosarcoma: A single-center review.Surgical treatment of pulmonary metastases in pediatric solid tumors.Multi-reoperations for lung metastases.Comprehensive treatment based on intra-arterial chemotherapy for distal femur neoplasms.Higher Gemcitabine Dose Was Associated With Better Outcome of Osteosarcoma Patients Receiving Gemcitabine-Docetaxel Chemotherapy.Factors associated with local recurrence in operated osteosarcomas: A retrospective evaluation of 95 cases from a tertiary care center in a resource challenged environment.Disintegrin targeting of an αvβ3 integrin-over-expressing high-metastatic human osteosarcoma with echistatin inhibits cell proliferation, migration, invasion and adhesion in vitro.Outcomes and clinical predictors of improved survival in a patients undergoing pulmonary metastasectomy for sarcoma.Factors predicting survival following complete surgical remission of pulmonary metastasis in osteosarcoma.Rare occurrence of bilateral breast and peritoneal metastases from osteogenic sarcoma.Combined treatment for single giant pulmonary metastasis from osteosarcoma: from inside to outside.Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS).PAK5 overexpression is associated with lung metastasis in osteosarcoma.Multiple relapses in high-grade osteosarcoma: when to stop aggressive therapy?The addition of mifamurtide to chemotherapy improves lifetime effectiveness in children with osteosarcoma: a Markov model analysis.Effect of Period 2 on the proliferation, apoptosis and migration of osteosarcoma cells, and the corresponding mechanisms.Treatment Outcomes in Children and Adolescents with Relapsed or Progressed Solid Tumors: a 20-year, Single-Center StudyCytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapyGATA3 is downregulated in osteosarcoma and facilitates EMT as well as migration through regulation of slug
P2860
Q24193790-28CF564E-F51D-41A8-AC00-F5129BA78EF4Q26752425-2D403D4A-139A-4039-97DD-7F800CC9A625Q26828595-1C545BF9-B536-4D9F-887E-C383EAB930EFQ28082935-97ADCBC3-BBAE-4D3B-BE88-0A76431EB173Q30527909-A1CAD707-34AB-4B71-AA19-D75EC2466A06Q33597266-4F1772ED-EA04-41E8-91C5-0B4ACBB2B17DQ34239326-C062E2B9-1E8E-47B6-B560-20CEF0045882Q34652142-649AEFFB-9B4C-4039-B0CF-1BA1401D08F7Q35677274-A2F35E62-7338-4979-BECE-42148D824178Q35759038-8FFCE958-B3F0-4D64-A3E4-98D6C0844881Q36014443-90AD058F-6FCB-40A4-B18F-6F0A364C047CQ37025508-95823377-9657-4277-A615-9FE9493E88C3Q37283506-EBFA9EAA-5084-41E2-AB07-06033DB7F3E0Q37640670-FF6B2E66-8E88-4514-B8D0-951085BEFF0BQ38291193-39C32D8B-7FA0-4AE2-B417-08F118B52EE0Q38506118-9BBFB946-8917-4DED-990E-087529787F0BQ38619114-F1F93409-23CC-4564-A860-9C54B91E537FQ38791215-9173FBAD-C4AC-412C-AE33-402034E0D852Q39005641-AFB3F106-A7EE-4FC1-85B6-CC28EECE3CA7Q39036563-4367BC68-265B-4794-B14A-499BCF9D5599Q39041997-95CBA541-6C4A-416C-A270-E0C018010ED8Q39232118-1667295D-8E03-48E6-8489-BFBC463E115FQ39752805-356E5BA6-164B-4B67-A54F-A2695972E99DQ40227330-9C909F44-EF6D-4CA1-AA20-64BA7EBC7130Q40854586-C10E69FF-DBC5-412C-8688-4D6ACD19AF15Q41582250-866DF997-8BCB-49E8-B299-1AA33D58FFCCQ41908993-A786869B-D222-42AD-A87E-9071F5123BEDQ44702676-2368B29A-F9BC-4AD4-A338-211C8B4F760FQ47358544-3B4116C2-C493-4E52-A1DD-051E35DA2668Q47633318-AEA65DB8-1667-4AE5-AC3A-39363230639EQ49422936-CF17AFAA-7F27-41B8-8E58-FBCE71A680D7Q50850250-FAF59B8D-2E64-4A35-8FA8-97F358AA2041Q51731822-056FCDB7-FF4B-437D-A287-121B9B861912Q55718061-B2EBE1A9-00EA-4BE5-B925-24FB118A4A2DQ57116898-670A0F78-00DB-4DA8-88FE-92FB3C4DCA85Q58566155-1981B22A-6D2C-41F5-B25A-909E61EF2483Q59135270-6B272F0C-F6F9-44FD-8928-66D559E2B35D
P2860
Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Survival after recurrent osteo ...... randomized controlled trials.
@ast
Survival after recurrent osteo ...... randomized controlled trials.
@en
type
label
Survival after recurrent osteo ...... randomized controlled trials.
@ast
Survival after recurrent osteo ...... randomized controlled trials.
@en
prefLabel
Survival after recurrent osteo ...... randomized controlled trials.
@ast
Survival after recurrent osteo ...... randomized controlled trials.
@en
P2093
P1476
Survival after recurrent osteo ...... randomized controlled trials.
@en
P2093
Anne McTiernan
Antonie H M Taminiau
European Osteosarcoma Intergroup
Hans Gelderblom
Ian J Lewis
Jeremy Whelan
Marianne A Nooij
Martine van Glabbeke
Pancras C W Hogendoorn
Rachel C Jinks
P304
P356
10.1016/J.EJCA.2010.11.036
P577
2011-01-06T00:00:00Z